Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Fleury S.A.
  6. News
  7. Summary
    FLRY3   BRFLRYACNOR5

FLEURY S.A.

(FLRY3)
  Report
End-of-day quote. End-of-day quote Bolsa de Valores de Sao Paulo - 10/18
21.66 BRL   +1.36%
07/30Fleury to Seek Acquisitions
CI
07/29Fleury S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/29FLEURY S A : Earnings Release - 2Q21
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Fleury S A : Comunicado ao Mercado

06/24/2021 EDT

FLEURY S.A.

Companhia Aberta

CNPJ/ME nº 60.840.055/0001-31

NIRE 35.300.197.534

COMUNICADO AO MERCADO

  • Fleury S.A. ("Grupo Fleury" ou "Companhia"), em continuidade às informações divulgadas nos

comunicados ao mercado de 22 e 23 de junho de 2021, e como parte das atualizações sobre a indisponibilidade dos sistemas da Companhia, provocada pela tentativa de ataque cibernético, informa aos seus acionistas e ao mercado em geral que começou a restabelecer esses sistemas internos em hospitais. Esta foi a prioridade da Companhia desde o início do incidente, em face da criticidade na assistência a pacientes internados. Paralelamente, seguimos atendendo nossos pacientes em todas as nossas Unidades de Atendimento por meio de soluções de contingência.

Reiteramos que nossa base de dados está íntegra e destacamos que não há quaisquer evidências de vazamento de dados e informações sensíveis.

A Companhia segue contando com a atuação de empresas de referência em tecnologia, segurança da informação, bem como de quality assurance, ou seja, de auditoria dedicada a certificar a qualidade do processo de restabelecimento das nossas operações de atendimento. A Companhia seguirá informando o mercado acerca da evolução dos trabalhos de restauração integral e normalização dos nossos sistemas.

São Paulo, 24 de junho de 2021.

FERNANDO AUGUSTO RODRIGUES LEÃO FILHO

Diretor Executivo de Finanças e Relações com Investidores

FLEURY S.A.

Public Held Company

Company Taxpayer's ID (CNPJ) 60.840.055/0001-31

Company Registry (NIRE) 35.300.197.534

NOTICE TO THE MARKET

Fleury SA ("Fleury Group" or "Company"), in continuity with the information disclosed in the notices to the market of June 22 and 23, 2021, and as part of the updates on the unavailability of the Company's systems, caused by the attempt of a cyber-attack, informs its shareholders and the market in general that started to reestablish the internal systems at the hospitals. This was the priority of the Company since the beginning of this incident, given the criticality of care for inpatients. At the same time, we continue to care for our patients in all our Patient Service Centers through contingency solutions.

We reiterate that our database is integrate and we emphasize that there is no evidence of leakage of data and sensitive information.

The Company continues to rely with the work of leading companies in technology, information security, as well as quality assurance, in other words, an audit dedicated to certifying the quality of the process of reestablishment of our service operations.

The Company will continue to inform the market about the evolution of the integral restoration and normalization work of our systems.

São Paulo, June 24th, 2021

FERNANDO AUGUSTO RODRIGUES LEÃO FILHO

Chief Financial and Investor Relations Officer

Disclaimer

Fleury SA published this content on 24 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2021 12:53:03 UTC.


© Publicnow 2021
All news about FLEURY S.A.
07/30Fleury to Seek Acquisitions
CI
07/29Fleury S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/29FLEURY S A : Earnings Release - 2Q21
PU
07/29FLEURY S A : Financial Statements - 2Q21
PU
06/24FLEURY S A : Comunicado ao Mercado
PU
04/30Fleury to Seek Acquisitions
CI
04/29FLEURY S A : Financial Statements - 1Q21
PU
04/29Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
02/25Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
02/16Brazil's overwhelmed healthcare system spawns bonanza for dealmakers
RE
More news
Financials
Sales 2021 3 535 M 642 M 642 M
Net income 2021 347 M 63,1 M 63,1 M
Net Debt 2021 1 862 M 338 M 338 M
P/E ratio 2021 19,4x
Yield 2021 4,17%
Capitalization 6 837 M 1 238 M 1 242 M
EV / Sales 2021 2,46x
EV / Sales 2022 2,28x
Nbr of Employees 15 000
Free-Float 54,8%
Chart FLEURY S.A.
Duration : Period :
Fleury S.A. Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | MarketScreener
Technical analysis trends FLEURY S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 21,66 BRL
Average target price 29,06 BRL
Spread / Average Target 34,2%
EPS Revisions
Managers and Directors
Jeane Mike Tsutsui Chief Executive Officer
José Antônio de Almeida Filippo Director-Finance & Investor Relations
Marcio Pinheiro Mendes Chairman
Edgar Gil Rizzatti Head-Medical, Technical & Process
Andrea Cristina de Lima Rolim Independent Director
Sector and Competitors
1st jan.Capi. (M$)
FLEURY S.A.-19.84%1 245
SONIC HEALTHCARE LIMITED20.96%13 922
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-23.04%7 449
NEOGENOMICS, INC.-19.43%5 334
DR. LAL PATHLABS LIMITED56.37%4 058
FULGENT GENETICS, INC.49.75%2 303